T. Rowe Price Investment Management’s Eli Lilly LLY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $780M | Sell |
1,001,037
-114,339
| -10% | -$89.1M | 0.49% | 48 |
|
|
2025
Q1 | $921M | Buy |
1,115,376
+324,598
| +41% | +$268M | 0.61% | 39 |
|
|
2024
Q4 | $610M | Buy |
790,778
+14,927
| +2% | +$11.5M | 0.38% | 76 |
|
|
2024
Q3 | $687M | Sell |
775,851
-213,428
| -22% | -$189M | 0.41% | 69 |
|
|
2024
Q2 | $896M | Sell |
989,279
-120,355
| -11% | -$109M | 0.57% | 48 |
|
|
2024
Q1 | $863M | Sell |
1,109,634
-2,435
| -0.2% | -$1.89M | 0.53% | 57 |
|
|
2023
Q4 | $648M | Sell |
1,112,069
-194,326
| -15% | -$113M | 0.42% | 75 |
|
|
2023
Q3 | $702M | Sell |
1,306,395
-6,704
| -0.5% | -$3.6M | 0.5% | 52 |
|
|
2023
Q2 | $616M | Sell |
1,313,099
-13,260
| -1% | -$6.22M | 0.42% | 67 |
|
|
2023
Q1 | $455M | Buy |
1,326,359
+107,400
| +9% | +$36.9M | 0.33% | 89 |
|
|
2022
Q4 | $446M | Buy |
+1,218,959
| New | +$446M | 0.34% | 84 |
|